The abnormal inflammatory state in SLE patients is characterized by excessive and improper functions of immune effector cells, along with elevated circulating levels of certain pro-inflammatory cytokines including IL-6, IL-1β, and TNFα, which ultimately lead to damage of the target tissue (3, 4). The gene discussed is TNF; the disease is systemic lupus erythematosus.